Article Details
Retrieved on: 2024-12-06 16:30:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Organigram's acquisition of Motif Labs, strengthening its market position in Canada's cannabis sector, particularly non-medical and vaping products. The key concept of 'Medical cannabis' is only briefly relevant, as Organigram's sales are predominantly in the recreational sector, supported by partnerships with companies like British American Tobacco.
Article found on: stratcann.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here